Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Med USA is a privately held U.S. healthcare company focused on FDA-cleared medical, aesthetic, surgical, dental, and diagnostic products. The company presents itself as a manufacturer and distributor serving domestic and international markets, with a product portfolio spanning rapid diagnostic kits, ophthalmic imaging, aesthetic laser/IPL systems, LED skin-treatment devices, and dental laser equipment. Its offerings appear to be largely commercialized devices rather than a traditional therapeutic drug pipeline. Bio-Med USA also advertises 510(k) regulatory consulting services, suggesting capabilities in product commercialization and device-market entry support. The company is based in Paterson, New Jersey and is led by founder and CEO Young Chi.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Med USA.